Achyut Healthcare logo

Achyut Healthcare share price

BSE: 543499Pharmaceuticals & BiotechnologySmall Cap

Achyut Healthcare Limited · Face value ₹1 · Listed Mar 2022
Last close ₹7.66up ₹0.36 (4.93%)

Share price at the BSE close on 27 Oct 2026. Previous close ₹7.30.

27 Oct: open ₹6.94, high ₹7.66, low ₹6.94

52-week range of traded prices to 27 Oct 2026
₹4.70Low, 13 May 2026₹10.04High, 24 Jun 2026
Market cap
₹185 Cr2,685th largest listed
P/E
Earlier quarters restated in the year
P/B
5.24
Dividend yield
Nonein the last 12 months
ROCE
0.2%
Debt to equity
0.00
Volume, BSE
5,21,448

Achyut Healthcare share price chart

Daily closes since Mar 2022, adjusted for splits and bonuses

+29.2%over a year · Nifty 500 −7.8%

20-session average 1,43,906 shares a day

Results

Standalone; ₹ crore.Achyut Healthcare quarterly results

Quarter to Sep 2026, against the quarter before

Revenue
₹1.66 Crdown 46.90%
Net profit
₹0.05 Crdown 65.41%
Net margin
3.0%

Revenue by quarter

₹1.57 CrDec 25₹4.39 CrMar 26₹3.13 CrJun 26₹1.66 CrSep 26
Peak revenue ₹4.39 Cr, quarter to Mar 2026; lowest ₹1.57 Cr, quarter to Dec 2025

Net profit by quarter, a loss in red

₹0.00 CrDec 25₹0.06 CrMar 26₹0.14 CrJun 26₹0.05 CrSep 26
₹ croreDec 2025Mar 2026Jun 2026Sep 2026
Revenue1.574.393.131.66
Net profit0.000.060.140.05
Net margin0.3%1.3%4.6%3.0%
Standalone. The 4 quarters from Dec 2025, the first on record; the half years before them are below. The latest is shaded.
₹ croreMar 2025Sep 2025
Revenue0.925.64
Net profit0.200.23
Net margin21.2%4.1%
Standalone. The half years in the same span that the quarters on record do not fully cover.

Business segments

In the year to Mar 2026 the company reports one business segment, Pharmaceuticals, which carries all its revenue.

Where the return came from

Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.

OverReturn a yearEarnings growthChange in P/EDividend yield
1 year+61.7%−43.7%+187.3%0.0%
3 years+26.5%+3.6%+22.1%0.0%
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1 and 3 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.

Shareholding

Per cent of the company's shares, from the filing for Sep 2026.Achyut Healthcare shareholding pattern

Shareholding by group

  • Promoters47.40%
  • Foreign institutions5.13%
  • Individuals and others47.47%
Holder
DHARAM PRAKASH TRIPATHIResident individuals, over ₹2 lakh at face value15.87%
MAHENDRA CHATRABHUJ RAYCHAPromoter11.01%
ZENITH MEDICINE PRIVATE LIMITEDPromoter9.52%
RAYCHA AKSHIT MAHENDRAPromoter8.95%
MAHENDRA C RAYCHA HUFPromoter7.95%
ISEM MEHMETForeign portfolio investors, category II5.13%
Holders are named in the company's own words: an insurer's holding can carry one of its funds' names.

Since Jun 2026: promoters unchanged, foreign institutions unchanged.

The filing reports 5,26,90,270 of its 24,13,57,000 shares locked in.

Promoter and insider buying and selling

Trades made since 28 Oct 2025.Achyut Healthcare insider trading

Bought on the market Sold on the market
  • Promoters and promoter group26 purchases, 0 sales₹0.87 CrNo saleNet₹0.87 Cr4 off-market moves
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.

Achyut Healthcare competitors and peers

Pharmaceuticals, 216 listed companies, priced on 27 Oct 2026. The table lists the 8 companies closest to Achyut Healthcare in market cap. 1 company in the table last traded before then: its row is priced on its last trade.Healthcare companies

Achyut Healthcare is not on the chart: it has no P/E or return on equity today

Return on equity across, P/E up, size is market cap
Company
Accretion Nutraveda logoAccretion NutravedaANL19738.835.55––14.3%–0.00%
Kerala Ayurveda logoKerala AyurvedaKERALAYUR196––+10.4%–−257.3%−24.1%0.00%
Bio Medica LaboratoriesBMLL19516.69–––44.2%–0.00%
Syschem (India) logoSyschem (India)SYSCHEM192–1.38+40.3%––10.4%0.00%
Brooks Laboratories logoBrooks LaboratoriesBROOKS17613.321.43−7.7%+550.4%12.0%3.2%0.00%
Coral Laboratories logoCoral LaboratoriesCORALAB1759.140.84−5.4%+7.2%9.4%7.6%0.41%
Oxygenta Pharmaceutical logoOxygenta PharmaceuticalOXYGENTAPH173––+20.6%––−15.1%0.00%
Medico Remedies logoMedico RemediesMEDICO16912.272.25+50.0%+33.7%20.1%15.3%0.00%
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.

Latest announcements

Routine notices left out.Achyut Healthcare announcements

Achyut Healthcare share price by year

Each calendar year to 2025.Achyut Healthcare share price history

YearClose at year endChangeHighest closeLowest close
20255.50+38.9%6.512.96
20243.96−4.4%5.962.87
20234.14+246.6%4.181.25
20221.20–1.400.81
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2023 is from its first session, 30 Jan 2023. 2022 is from its first session, 30 Mar 2022.

Recent sessions

The 9 trading days to 26 Oct 2026, as traded on BSE; the latest is at the top of the page.

DateOpenHighLowCloseAverage priceVolume
26 Oct 20267.307.306.677.307.298,18,760
23 Oct 20266.966.966.966.966.9640,407
22 Oct 20266.636.636.636.636.6312,921
21 Oct 20266.326.326.326.326.3245,477
19 Oct 20266.026.026.026.026.022,65,372
16 Oct 20265.745.745.505.745.7372,388
15 Oct 20265.305.475.075.475.4085,099
14 Oct 20265.005.224.895.215.1783,334
13 Oct 20265.295.294.974.985.011,40,840
Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.Bonus shares and stock split history

Ex-dateEventPrice factorWhat happened
10 Dec 2024Bonus0.7143Holders received 2 bonus shares for every 5 held.
10 Dec 2024Split0.1000Each share became 10.
25 Apr 2023Bonus0.6667Holders received 1 bonus share for every 2 held.
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.

Company details

Chairperson
MAHENDRA CHATRABHUJ RAYCHA
At the end of the quarter to Sep 2026
Managing director
JIGEN JAGDISHBHAI MODI
At the end of the quarter to Sep 2026
BSE code
543499
ISIN
INE0K1401020
Industry
Pharmaceuticals & Biotechnology
CIN
L67120GJ1996PLC028600
Corporate identity number, the registrar of companies' code for it
Incorporated
1996
Registered office
610 Colonade, Iscon - Ambali Road, B/H Iscon Temple, Opposite Iscon, BRTS Bus Stand, Ahmedabad 380058, Gujarat
Share registrar
KFin Technologies Ltd
Keeps the register of shareholders and handles transfers and dividend payments